Mathieu LN, Larkins E, Sinha AK, Mishra-Kalyani PS, et al. FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC. Clin Cancer Res 2023;29:2973-2978.
PMID: 36951523